# Alpha Cognition Inc. Common Stock (ACOG)

> Source: Nexqual · https://nexqual.com/ACOG · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, Alpha Cognition Inc. Common Stock (ACOG), nexqual.com/ACOG" · informational, not investment advice.

**Price:** USD 8.45 (-2.31% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 8.65 · day 8.18–8.75 · 52w 4.5–10.14 · market cap $184M · NCM

## Key facts
- Analysts: Buy (mean 1.50 on a 1–5 scale) (6 analysts), mean target USD 18 (range 12–21).
- Total return with dividends: 1Y +19.7% vs S&P 500 +18.1%; 5Y +57.4% vs S&P 500 +85.1%.
- Next earnings: 2026-11-12, EPS estimate USD -0.33, revenue estimate $9.9M.

## Analysts
Consensus Buy (mean 1.50 on a 1–5 scale), 6 analysts; mean target USD 18 (low 12, high 21).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-08-20 | B. Riley Securities | Initiated | Buy | $21 |
| 2026-08-17 | HC Wainwright & Co. | Target raised | Buy | $18 → $20 |
| 2026-07-10 | Raymond James | Initiated | Outperform | $20 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2024-11-11) |
|---|---|---|
| Total return | +19.7% | +57.4% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | +19.8% | +26.5% |
| Volatility (annualized) | 62.7% | 67.2% |
| Max drawdown | -36.9% (Oct 2025→Feb 2026) | -55.3% (Jul 2025→Jan 2026) |

## Peers (Biotechnology)
RYTM (Rhythm Pharmaceuticals, Inc.) USD 87.97 +1.57% · BLTE (Belite Bio, Inc) USD 152.62 +0.49% · IOVA (Iovance Biotherapeutics, Inc.) USD 14.72 +1.52% · PRAX (Praxis Precision Medicines, Inc) USD 248.24 +2.01% · IONS (Ionis Pharmaceuticals, Inc.) USD 44.12 +4.11% · SYRE (Spyre Therapeutics, Inc.) USD 80.1 -0.44%

## More
Full page: https://nexqual.com/ACOG · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt